NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118 | – | 25,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,670,136 | $26,472,000 | 4.12% |
| Orbimed Advisors | 4,012,281 | $63,595,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 444,572 | $7,046,000 | 0.59% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 453,012 | $7,180,000 | 0.11% |
| Bellevue Group AG | 507,930 | $8,051,000 | 0.08% |
| JOHNSON & JOHNSON | 55,435 | $879,000 | 0.08% |
| Nantahala Capital Management | 141,641 | $2,245,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 359,421 | $5,697,000 | 0.01% |
| PICTET ASSET MANAGEMENT SA | 569,875 | $9,033,000 | 0.01% |
| Ghisallo Capital Management LLC | 15,000 | $238,000 | 0.01% |